Abstract
While virus-like particles (VLPs) containing subgenomic replicons, which can transduce replicons into target cells efficiently for studying viral replication and vectors of gene therapy and vaccine, have been established for several flaviviruses, none has been reported for the four serotypes of dengue virus, the causal agent of the most important arboviral diseases in this century. In this study, we successfully established a cell line stably expressing the precursor membrane/envelope (PrM/E) proteins of dengue virus type 2 (DENV2), which can package a DENV2 replicon with deletion of PrM/E genes and produce single-round infectious VLPs. Moreover, it can package a similar replicon of different serotype, dengue virus type 4, and produce infectious chimeric VLPs. To our knowledge, this study reports for the first time replicon-containing VLPs of dengue virus. Moreover, this convenient system has potential as a valuable tool to study encapsidation of dengue virus and to develop novel chimeric VLPs containing dengue virus replicon as vaccine in the future.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 10: 100–103, 2002
Guzman M.G., Kouri G., Dengue: an update. Lancet Infect. Dis. 2: 33–42, 2002
World Health Organization, Dengue Hemorrhagic Fever, Diagnosis, Treatment and Control. 2 edn. Geneva, World Health Organization, 1997
Lindenbach B.D., Rice C.M., Flaviviridae: the viruses and their replication. In: D.M. Knipe, P.M. Howley, D.E. Griffin (Eds), Fields Virology, pp. 991–1041. Lippincott William & Wilkins: Philadelphia,PA., 2001
Ferlenghi I., Clarke M., Ruttan T., Allison S.L., Schalich J., Heinz F.X., Harrison S.C., Rey F.A., Fuller S.D., Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol. Cell 7: 593–602, 2001
Konishi E., Pincus S., Paoletti E., Shope R.E., Burrage T., Mason P.W., Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology 188: 714–720, 1992
Schalich J., Allison S.L., Stiasny K., Mandl C.W., Kunz C., Heinz F.X., Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J. Virol. 70: 4549–4557, 1996
Blight K.J., Kolykhalov A.A., Rice C.M., Efficient initiation of HCV RNA replication in cell culture. Science 290: 1972–1974, 2000
Khromykh A.A., Replicon-based vectors of positive strand RNA viruses. Curr. Opin. Mol. Ther. 2: 555–569, 2000
Khromykh A.A., Sedlak P.L., Westaway E.G., Cis- and trans-acting elements in flavivirus RNA replication. J. Virol. 74: 3253–3263, 2000
Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R., Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110–113, 1999
Hewson R., RNA viruses: emerging vectors for vaccination and gene therapy. Mol. Med. Today 6: 28–35, 2000
Schlesinger S., Alphavirus expression vectors. Adv. Virus Res. 55: 565–577, 2000
Gehrke R., Ecker M., Aberle S.W., Allison S.L., Heinz F.X., Mandl C.W., Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line. J. Virol. 77: 8924–8933, 2003
Hayasaka D., Yoshii K., Ueki T., Iwasaki T., Takashima I., Sub-genomic replicons of Tick-borne encephalitis virus. Arch. Virol. 149: 1245–1256, 2004
Holden K.L., Stein D.A., Pierson T.C., Ahmed A.A., Clyde K., Iversen P.L., Harris E., Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3′ stem-loop structure. Virology 344: 439–452, 2006
Jones C.T., Patkar C.G., Kuhn R.J., Construction and applications of yellow fever virus replicons. Virology 331: 247–259, 2005
Khromykh A.A., Westaway E.G., Subgenomic replicons of the flavivirus Kunjin: construction and applications. J. Virol. 71: 1497–1505, 1997
Pang X., Zhang M., Dayton A.I., Development of dengue virus type 2 replicons capable of prolonged expression in host cells. BMC Microbiol. 1: 18, 2001
Shi P.Y., Tilgner M., Lo M.K., Construction and characterization of subgenomic replicons of New York strain of West Nile virus. Virology 296: 219–233, 2002
Harvey T.J., Liu W.J., Wang X.J., Linedale R., Jacobs M., Davidson A., Le T.T., Anraku I., Suhrbier A., Shi P.Y., Khromykh A.A., Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J. Virol. 78: 531–538, 2004
Khromykh A.A., Varnavski A.N., Westaway E.G., Encapsidation of the flavivirus kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans. J. Virol. 72: 5967–5977, 1998
Pierson T.C., Sanchez M.D., Puffer B.A., Ahmed A.A., Geiss B.J., Valentine L.E., Altamura L.A., Diamond M.S., Doms R.W., A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346: 53–65, 2006
Puig-Basagoiti F., Deas T.S., Ren P., Tilgner M., Ferguson D.M., Shi P.Y., High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery. Antimicrob. Agents Chemother. 49: 4980–4988, 2005
Scholle F., Girard Y.A., Zhao Q., Higgs S., Mason P.W., Trans-packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J. Virol. 78: 11605–11614, 2004
Varnavski A.N., Khromykh A.A., Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes. Virology 255: 366–375, 1999
Yoshii K., Hayasaka D., Goto A., Kawakami K., Kariwa H., Takashima I., Packaging the replicon RNA of the Far-Eastern subtype of tick-borne encephalitis virus into single-round infectious particles: development of a heterologous gene delivery system. Vaccine 23: 3946–3956, 2005
Blaney J.E. Jr., Hanson C.T., Hanley K.A., Murphy B.R., Whitehead S.S., Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2. BMC Infect. Dis. 4: 39, 2004
Lai C.J., Zhao B.T., Hori H., Bray M., Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc. Natl. Acad. Sci. USA 88: 5139–5143, 1991
Bray M., Lai C.J., Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc. Natl. Acad. Sci. USA 88: 10342–10346, 1991
Wang W.K., Chen H.L., Yang C.F., Hsieh S.C., Juan C.C., Chang S.M., Yu C.C., Lin L.H., Huang J.H., King C.C., Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin. Infect. Dis. 43: 1023–1030, 2006
Henchal E.A., Gentry M.K., McCown J.M., Brandt W.E., Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am. J. Trop. Med. Hyg. 31:830–836, 1982
Chang G.J., Hunt A.R., Holmes D.A., Springfield T., Chiueh T.S., Roehrig J.T., Gubler D.J., Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus. Virology 306: 170–180, 2003
Chang G.J., Hunt A.R., Davis B., A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J. Virol. 74: 4244–4252, 2000
Chen C., Okayama H., High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7: 2745–2752, 1987
Wang W.K., Lee C.N., Kao C.L., Lin Y.L., King C.C., Quantitative competitive reverse transcription-PCR for quantification of dengue virus RNA. J. Clin. Microbiol. 38:3306–3310, 2000
Holmes D.A., Purdy D.E., Chao D.Y., Noga A.J., Chang G.J., Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections. J. Clin. Microbiol. 43: 3227–3236, 2005
Durbin A.P., Karron R.A., Sun W., Vaughn D.W., Reynolds M.J., Perreault J.R., Thumar B., Men R., Lai C.J., Elkins W.R., Chanock R.W., Murphy B.R., Whitehead S.S., Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region. Am. J. Trop. Med. Hyg. 65: 405–413, 2001
Anraku I., Harvey T.J., Linedale R., Gardner J., Harrich D., Suhrbier A., Khromykh A.A., Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity. J. Virol. 76: 3791–3799, 2002
Harvey T.J., Anraku I., Linedale R., Harrich D., Mackenzie J., Suhrbier A., Khromykh A.A., Kunjin virus replicon vectors for human immunodeficiency virus vaccine development. J. Virol. 77: 7796–7803, 2003
Lo M.K., Tilgner M., Shi P.Y., Potential high-throughput assay for screening inhibitors of West Nile virus replication. J. Virol. 77: 12901–12906, 2003
Rossi S.L., Zhao Q., O’Donnell V.K., Mason P.W., Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action. Virology 331: 457–470, 2005
Chen W., Kawano H., Men R., Clark D., Lai C.J., Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. J.Virol. 69: 5186–5190, 1995
Huang C.Y., Butrapet S., Pierro D.J., Hang G.J.J., Hunt A.R., Bhamarapravati N., Gubler D.J., Kinney R.M., Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J. Virol. 74: 3020–3028, 2000
Huang C.Y., Butrapet S., Tsuchiya K.R., Bhamarapravati N., Gubler D.J., Kinney R.M., Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. J. Virol. 77: 11436–11447, 2003
Blaney J.E. Jr., Durbin A.P., Murphy B.R., Whitehead S.S., Development of a live attenuated dengue virus vaccine using reverse genetics. Viral Immunol. 19: 10–32, 2006
Lai C.J., Monath T.P., Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Adv. Virus Res. 61: 469–509, 2003
Pugachev K.V., Guirakhoo F., Monath T.P., New developments in flavivirus vaccines with special attention to yellow fever. Curr. Opin. Infect. Dis. 18: 387–394, 2005
Sabchareon A., Lang J., Chanthavanich P., Yoksan S., Forrat R., Attanath P., Sirivichayakul C., Pengsaa K., Pojjaroen-Anant C., Chambonneau L., Saluzzo J.F., Bhamarapravati N., Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children. Pediatr. Infect. Dis. J. 23: 99–109, 2004
Blaney J.E. Jr., Matro J.M., Murphy B.R., Whitehead S.S., Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. J. Virol. 79: 5516–5528, 2005
Durbin A.P., Whitehead S.S., McArthur J., Perreault J.R., Blaney J.E. Jr., Thumar B., Murphy B.R., Karron R.A., rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers. J. Infect. Dis. 191: 710–718, 2005
Falgout B., Bray M., Schlesinger J.J., Lai C.J., Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J. Virol. 64: 4356–4363, 1990
Schlesinger J.J., Brandriss M.W., Cropp C.B., Monath T.P., Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J. Virol. 60: 1153–1155, 1986
Acknowledgments
We thank Dr. G. J. J. Chang at the Center for Disease Control and Prevention, Fort Collins for kindly providing the plasmid, pCBD2-2J-2-9-1, Dr. C. J. Lai at the National Institute of Health for the plasmid p2AXhoI, Dr. S. S. Whitehead at the National Institute of Health for the plasmids p2 and p4, Dr. H. C. Wu at the Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan for the Mab DB29-1. This work was supported by the National Science Council Taiwan (NSC95-2320-B-002-084-MY3).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lai, CY., Hu, HP., King, CC. et al. Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2. J Biomed Sci 15, 15–27 (2008). https://doi.org/10.1007/s11373-007-9204-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11373-007-9204-0